STOCK TITAN

Williams Jr affiliates sell 1M Aveanna (AVAH) shares at $8 in Form 4

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. insider filing shows entities associated with Robert M. Williams Jr. reported open‑market sales of a combined 1,000,000 shares of common stock at $8.00 per share on June 24, 2026. The sales were made by JHW Iliad Holdings II LLC, JHW Iliad Holdings LLC and J.H. Whitney VII, L.P., all reported as indirect holdings.

After these transactions, the filing shows 245,251 shares held by JHW Iliad Holdings II LLC, 2,339,639 shares held by JHW Iliad Holdings LLC and 12,531,158 shares held by J.H. Whitney VII, L.P., with additional indirect holdings at PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC. Footnotes state that Williams, through various management roles, may be deemed to share voting and dispositive power over these entities’ shares but disclaims beneficial ownership except for his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider WILLIAMS ROBERT M JR
Role 10% Owner
Sold 1,000,000 shs ($8.00M)
Type Security Shares Price Value
Sale Common Stock, $0.01 par value 919,389 $8.00 $7.36M
Sale Common Stock, $0.01 par value 72,963 $8.00 $584K
Sale Common Stock, $0.01 par value 7,648 $8.00 $61K
holding Common Stock, $0.01 par value -- -- --
holding Common Stock, $0.01 par value -- -- --
holding Common Stock, $0.01 par value -- -- --
Holdings After Transaction: Common Stock, $0.01 par value — 12,531,158 shares (Indirect, By J.H. Whitney VII, L.P.); Common Stock, $0.01 par value — 2,339,639 shares (Indirect, By JHW Iliad Holdings LLC); Common Stock, $0.01 par value — 245,251 shares (Indirect, By JHW Iliad Holdings II LLC); Common Stock, $0.01 par value — 0 shares (Direct); Common Stock, $0.01 par value — 15,523,810 shares (Indirect, By PSA Healthcare Investment Holdings LLC); Common Stock, $0.01 par value — 1,426,034 shares (Indirect, By PSA Iliad Holdings LLC)
Footnotes (4)
  1. F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  2. F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  3. F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  4. F4. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Shares sold 1,000,000 shares Open-market sales on June 24, 2026
Sale price $8.00 per share Price for reported open-market sales
JHW Iliad II post-sale holdings 245,251 shares Indirect holdings after transactions
JHW Iliad Holdings post-sale holdings 2,339,639 shares Indirect holdings after transactions
J.H. Whitney VII post-sale holdings 12,531,158 shares Indirect holdings after transactions
PSA Iliad Holdings position 1,426,034 shares Indirect holding entry as of June 24, 2026
PSA Healthcare Investment position 15,523,810 shares Indirect holding entry as of June 24, 2026
voting and dispositive power financial
"may be deemed to share voting and dispositive power with respect to the Shares"
beneficial ownership financial
"disclaims beneficial ownership of such securities except to the extent of its pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein"
indirect ownership financial
"ownership_type": "indirect" and nature_of_ownership noted by various LLC and L.P. entities"
open-market sale financial
"transaction_action": "open-market sale" for the S-coded transactions"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did the Aveanna (AVAH) Form 4 filed by Robert M. Williams Jr report?

The Form 4 reports that entities associated with Robert M. Williams Jr executed open‑market sales totaling 1,000,000 shares of Aveanna common stock at $8.00 per share on June 24, 2026, and discloses the entities’ remaining indirect holdings.

How many Aveanna (AVAH) shares were sold and at what price?

The filing shows open‑market sales of 1,000,000 shares of Aveanna common stock at $8.00 per share. These sales were reported across three indirect holding entities tied to J.H. Whitney investment vehicles associated with Robert M. Williams Jr.

Which entities associated with Robert M. Williams Jr sold Aveanna (AVAH) shares?

The sales were attributed to JHW Iliad Holdings II LLC, JHW Iliad Holdings LLC and J.H. Whitney VII, L.P. The Form 4 labels all of these positions as indirect holdings, with Williams connected through management and membership roles in related managing entities.

What Aveanna (AVAH) shareholdings remain after the reported Form 4 sales?

After the June 24, 2026 sales, the filing shows 245,251 shares held by JHW Iliad Holdings II LLC, 2,339,639 shares held by JHW Iliad Holdings LLC, and 12,531,158 shares held by J.H. Whitney VII, L.P., plus additional indirect holdings at PSA Iliad Holdings and PSA Healthcare Investment Holdings.

Does Robert M. Williams Jr personally own the Aveanna (AVAH) shares reported?

Footnotes state that Williams may be deemed to share voting and dispositive power over shares held by several stockholder entities but disclaims beneficial ownership of those securities except to the extent of his pecuniary interest in the entities.

Are the Aveanna (AVAH) insider sales reported on the Form 4 direct or indirect holdings?

All reported sales involve indirect holdings. The Form 4 classifies the transactions as indirect, with ownership noted as by JHW Iliad Holdings II LLC, JHW Iliad Holdings LLC and J.H. Whitney VII, L.P., rather than direct personal holdings of Robert M. Williams Jr.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WILLIAMS ROBERT M JR

(Last)(First)(Middle)
C/O J.H. WHITNEY CAPITAL PARTNERS, LLC
212 ELM STREET

(Street)
NEW CANAAN CONNECTICUT 06840

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value0D(4)
Common Stock, $0.01 par value06/24/2026S919,389D$812,531,158IBy J.H. Whitney VII, L.P.(1)
Common Stock, $0.01 par value15,523,810IBy PSA Healthcare Investment Holdings LLC(1)
Common Stock, $0.01 par value06/24/2026S72,963D$82,339,639IBy JHW Iliad Holdings LLC(2)
Common Stock, $0.01 par value1,426,034IBy PSA Iliad Holdings LLC(1)
Common Stock, $0.01 par value06/24/2026S7,648D$8245,251IBy JHW Iliad Holdings II LLC(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
4. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ David Zatlukal, Attorney-in-Fact06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)